Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use EMROSI safely and effectively. See full prescribing information for EMROSI. EMROSI TM (minocycline hydrochloride) extended-release capsules, for oral use Initial U.S. Approval: 1971
Medication labelWhy this: Advisory · dailymed-prescription
EMROSI is indicated to treat inflammatory lesions (papules and pustules) of rosacea in adults. Limitations of Use This formulation of minocycline has not been evaluated in the treatment or prevention of infections. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, use EMROSI only as indicated.
- generic_name
- minocycline hydrochloride extended-release
- product_names
- Minocycline Hydrochloride Extended-Release
- ndc
- 69489-131, 69489-131-30, 69489-131-07
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en